Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

Trichostasis spinulosa is a rare skin condition with hair-filled plugs in hair follicles.

RpoS helps Borrelia burgdorferi survive in hosts and adapt to different environments.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Retinoic acid production and signaling in hair follicles are regulated by location and timing, affecting hair growth and cycling.

Baricitinib can cause excessive hair growth.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Tridax procumbens may be a safe, affordable treatment for some health issues.

Trichotillomania can occur in unusual patterns and sites, highlighting the need for awareness and treatment options.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

JAK inhibitors show promise for treating various skin diseases.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions.

Murdha Taila, applied through the scalp, effectively treats head and neck issues and stimulates the nervous system.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.